Nerve function and regeneration in diabetic and galactosaemic rats: Antioxidant and metal chelator effects

European Journal of Pharmacology

Volumn 314, Issue 1-2, 1996, Pages 33-39

  Love, Alastair ^a   Cotter, Mary A ^a   Cameron, Norman E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

antioxidant; diabetes; galactosemia; metal chelator; nerve conduction; nerve regeneration; oxygen free radical; polyol pathway

Indexed keywords

ANTIOXIDANT; BUTYLCRESOL; CHELATING AGENT; FREE RADICAL; POLYOL; STREPTOZOCIN; TRIENTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; FREEZING; GALACTOSEMIA; MALE; MOTOR NERVE; MYELINATED NERVE; NERVE CONDUCTION; NERVE FUNCTION; NERVE INJURY; NERVE REGENERATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SCIATIC NERVE; SENSORY NERVE; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; BUTYLATED HYDROXYTOLUENE; CHELATING AGENTS; DIABETES MELLITUS, EXPERIMENTAL; GALACTOSEMIAS; MALE; NERVE REGENERATION; NEURAL CONDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; STREPTOZOCIN; TRIETHYLENETETRAMINE;

EID: 0030600493     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00528-6     Document Type: Article

References (42)

1. Apfel, S.C., J.C. Arezzo, M. Brownlee, H. Federoff and J.A. Kessler, 1994, Nerve growth factor administration protects against experimental diabetic sensory neuropathy, Brain Res. 634, 7.
2. Archibald, V., M.A. Cotter, A. Keegan and N.B. Cameron, 1996, Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments, Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 584.
3. Bondoux-Jahan, M. and A. Sebille, 1989, Conditioning lesion effects on rat sciatic nerve regeneration are influenced by electrical stimulation delivered to denervated muscles, Brain Res. 490, 350.
4. Bravenboer, B., A.C. Kapelle, F.P.T. Hamers, T. Van Buren, D.W. Erkelens and W.H. Gispen, 1992, Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat, Diabetologia 35, 813.
5. Brownlee, M., 1992, Glycation products and the pathogenesis of diabetic complications, Diabetes Care 15, 1835.
6. Calcutt, N.A., D. Muir, H.C. Powell and A.P. Mizisin, 1992, Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats. Brain Res. 575, 320.
7. Calcutt, N.A., H.F. McMurray, D.F. Moorehouse, M. Bache, S. Parthasarathy, H.C. Powell and A.P. Mizisin, 1994a, Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor, tolrestat. Exp. Neurol. 128, 262.
8. Calcutt, N.A., A.P. Mizisin and M.W. Kalichman, 1994b, Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve, Eur. J. Pharmacol. 251, 27.
9. Cameron, N.E. and M.A. Cotter, 1993, Contraction and relaxation of aortas from galactosaemic rats and the effects of polyol pathway inhibition, Eur. J. Pharmacol. 243, 47.
10. Cameron, N.E. and M.A. Cotter, 1994, The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications, Diabetes Metab. Rev. 10, 189.
11. Cameron, N.E. and M.A. Cotter, 1995, Neurovascular dysfunction in diabetic rats; potential contribution of autoxidation and free radicals examined using transition metal chelating agents, J. Clin. Invest. 96, 1159.
12. Cameron, N.B., M.B. Leonard, I. Ross and P. Whiting, 1986, The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin diabetic rat, Diabetologia 29, 168.
13. Cameron, N.E., M.A. Cotter, S. Robertson and D. Cox, 1992, Muscle and nerve dysfunction in rats with experimental galactosaemia, Exp. Physiol. 77, 89.
14. Cameron, N.E., M.A. Cotter and E.K. Maxfield, 1993, Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats, Diabelologia 36, 299.
15. Cameron, N.E., M.A, Cotter, K.C. Dines, E.K. Maxfield, F. Carey and D. Mirrlees, 1994, Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism, Diabetologia 37, 651.
16. Cameron, N.E., A. Love and M.A. Cotter, 1995, Ciliary neuronotrophic factor improves nerve conduction and regeneration in experimental diabetes, Diabetologia 38 (Suppl. 1), A233.
17. Cornblath, D.R. and M.J. Brown, 1988. Influence of malnutrition on developing rat peripheral nerves, Exp. Neurol. 99, 403.
18. Cotter, M.A., A. Love, M.J. Watt, N.E. Cameron and K.C. Dines, 1995, Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats, Diabetologia 38, 1285.
19. Dines, K.C., M.A. Cotter and N.E. Cameron, 1995, Nerve function in galactosaemic rats: effects of evening primrose oil and doxazosin, Eur. J. Pharmacol. 281, 303.
20. Dvornik, D., 1987, Hyperglycemia in the pathogenesis of diabetic complications, in: Aldose Reductase Inhibition. An Approach to the Prevention of Diabetic Complications, ed. D. Porte (Biomedical Information Corporation, New York, NY) p. 69.
21. Ekström, P.A.R. and D.R. Tomlinson, 1989, Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor, J. Neurol. Sci. 93, 231.
22. Fu, M.-X., K.J. Wells-Knecht, J.A. Blackledge, T.J. Lyons, S.R. Thorpe and J.W. Baynes, 1994, Glycation, glycoxidation and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard reaction, Diabetes 43, 676.
23. 2+ antagonist nimodipine counteracts the onset of an experimental neuropathy in streptozotocin induced, diabetic rats, Neurosci. Res. Commun. 10, 95.
24. 2 in human umbilical vein endothelial cells cultured in high glucose medium, Diabetologia 37, 264.
25. Keegan, A., V. Archibald, M.A. Cotter and N.E. Cameron, 1996, Transition metal chelators and anti-oxidants prevent the development of defective endothelium-dependent relaxation in aortas from diabetic rats, Diabetic Med. 13 (Suppl. 1), P9.
26. Kihara, M., J.D. Schmelzer, J.F. Poduslo, F.F. Curran, K.K. Nickander and P.A. Low, 1991, Aminoguanidine effect on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals, Proc. Natl. Acad. Sci. USA 88, 6107.
27. Longo, F.M., H.C. Powell, J. LeBeau, M.R. Gerrero, B.S. Heckman and R.R. Myers, 1986, Delayed nerve regeneration in streptozotocin diabetic rats, Muscle Nerve 9, 385.
28. Low, P.A., T.D. Lagerlund and P.G. McManis, 1989, Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31, 355.
29. 1 receptor antagonist, Am. J. Physiol. 269, E530.
30. McManis, P.G., P.A. Low and J.K. Yao, 1986, The relationship between nerve blood flow and intercapillary distance in peripheral nerve edema. Am. J. Physiol. 251, E92.
31. Myers, R.R. and H.C. Powell, 1984, Galactose neuropathy - impact of chronic endoneurial edema on nerve blood flow, Ann. Neurol. 16, 587.
32. Nagamatsu, M., K.K. Nickander, J.D. Schmelzer, A. Raya, A. Wittrock, H. Tritschler and P.A. Low, 1995, Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy, Diabetes Care 18, 1160.
33. Nukuda, H., 1988, Post-traumatic endoneurial neovascularization and nerve regeneration: a morphometric study. Brain Res. 449, 89.
34. Nukuda, H., P.J. Dyck and P.A. Low, 1986, Axon caliber and neurofilaments are proportionally decreased in galactose neuropathy, J. Neuropathol. Exp. Neurol. 45, 140.
35. Powell, H.C., F.M Longo, J. LeBeau and R.R. Myers, 1986, Abnormal nerve regeneration in galactose neuropathy, J. Neuropathol. Exp. Neurol. 45, 151.
36. +-dependent p-nitro-phenylphosphatase in rat peripheral nerve, Acta Neuropathol. 81, 529.
37. Sharma, A.K., S. Bajada and P.K. Thomas, 1981, Influence of streptozotocin-induced diabetes on myelinated nerve fibre maturation and integrity and on body growth in the rat, Acta Neuropathol. 53, 257.
38. Shupek, M., K.K. Ward, J.D. Schmelzer and P.A. Low, 1989, Comparison of nerve regeneration in vascularized and conventional grafts: nerve electrophysiology, norepinephrine, prostacyclin, malonaldehyde and the blood-nerve barrier, Brain Res. 493, 255.
39. Tesfaye S., R. Malik and J.D. Ward, 1994, Vascular factors in diabetic neuropathy, Diabetologia 37, 847.
40. Vinik, A.I., P.G. Newlon, T.J. Lauterio, F.J. Liuzzi, A.S. Depto, G.L. Pittenger and D.W. Richardson, 1995, Nerve survival and regeneration in diabetes, Diabetes Rev. 3, 139.
41. Williamson, J.R., K. Chang, M. Frangos, K.S. Hasan, Y. Ido, T. Kawamura, J.R. Nyengaard, M. Van Den Enden, C. Kilo and R.G. Tilton, 1993, Hyperglycenic pseudohypoxia and diabetic complications, Diabetes 42, 801.
42. Yagihashi S., 1995, Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab. Rev. 11, 193.